Trientine
Device
West-Ward Pharmaceuticals
Total Payments
$166,112
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $166,112 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $166,112 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Trientine Fasted Pivotal Study | West-Ward Pharmaceuticals | $166,112 | 0 |
Top Doctors Receiving Payments for Trientine
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | — | $166,112 | 1 |
Ad
Manufacturing Companies
- West-Ward Pharmaceuticals $166,112
Product Information
- Type Device
- Total Payments $166,112
- Total Doctors 0
- Transactions 1
About Trientine
Trientine is a device associated with $166,112 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is West-Ward Pharmaceuticals.
Payment data is available from 2017 to 2017. In 2017, $166,112 was paid across 1 transactions to 0 doctors.
The most common payment nature for Trientine is "Unspecified" ($166,112, 100.0% of total).
Trientine is associated with 1 research study, including "Trientine Fasted Pivotal Study" ($166,112).